NIH recently invested $11.3 million to find the most effective ways to diagnose, prevent, and treat HIV using highly effective methods that are already available, including pre- and post-exposure prophylaxis (PrEP and PEP) and antiretroviral therapy.
In this video conversation, Carl Dieffenbach, PhD, Director of the Division of AIDS at the National Institute of Allergy and Infectious Diseases, discusses NIH’s investment in these implementation research projects, which will take place in 43 of the 57 jurisdictions prioritized in Phase I of the Ending the HIV Epidemic: A Plan for America (EHE) initiative.
The funds will help researchers at 23 Centers for AIDS Research and AIDS Research Centers to investigate the best ways to deliver evidence-based interventions and services for those at disproportionate risk for HIV, including Black and Latinx women and men, transgender women, and youth aged 13-24 years. They will also work with local health officials and community groups to design and test implementation techniques that take local issues into account.
Read more about the implementation research awards in this blog post. To learn more about the Ending the HIV Epidemic initiative, visit HIV.gov and sign up for our listserv to stay up to date on the latest EHE developments.